Cancer Detection and Diagnosis Research in Indiana
Cancer Detection and Diagnosis Research (93.394) awarded $21.0 million to recipients in Indiana in 19 grants from fiscal 2021 to 2025, 0.8% of the program's national total. Trustees of Indiana University received the most, $12.9 million.
- Awarded in Indiana$21.0 million
- Awards19
- Share of the program0.8%
- Rank among states25th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 10 | $4.2 million |
| FY 2022 | 9 | $3.5 million |
| FY 2023 | 11 | $4.7 million |
| FY 2024 | 11 | $4.9 million |
| FY 2025 | 6 | $3.8 million |
Recipients in Indiana
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Trustees of Indiana University | Colleges and universities | 8 | $12.9 million |
| Purdue University | Colleges and universities | 3 | $4.3 million |
| Early Is Good, Inc. | Small businesses | 1 | $1.7 million |
| Tymora Analytical Operations LLC | Small businesses | 3 | $1.3 million |
| Amplified Sciences Inc | Small businesses | 1 | $454,885 |
| University of Notre Dame Du Lac | Colleges and universities | 1 | $402,404 |
| American Society of Preventive Oncology, Inc | Nonprofits | 2 | $90,000 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Indiana?
$21.0 million from fiscal 2021 to 2025, across 19 awards. Indiana ranks 25th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Indiana?
The largest recipient is Trustees of Indiana University, with $12.9 million in 8 awards. Next are Purdue University and Early Is Good, Inc..
Can organizations in Indiana apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Indiana
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Special Education Grants to States
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies
- Temporary Assistance for Needy Families
- Broadband Equity, Access, and Deployment Program